文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

肾及肾周脓肿患者急性肾损伤的相关因素与临床结局:2016-2022年全国住院患者样本分析

Factors Associated with Acute Kidney Injury and Clinical Outcomes in Patients with Renal and Perinephric Abscess: A National Inpatient Sample Analysis (2016-2022).
PubMed 文献 · Shock · 2025-11-03
一句话结论肾及肾周脓肿患者中约32.1%发生急性肾损伤,AKI与住院时间、费用、死亡率、机械通气、透析及经皮肾造瘘引流使用增加显著相关。

共4,896例(32.1%)发生AKI,发生率从2016年的29.9%上升至2022年的34.8%。多因素logistic回归显示年龄≥45岁、男性、黑人种族、多种合并症及并发症与AKI相关。AKI患者住院时间更长(中位9天 vs 5天)、费用更高(中位82,741美元 vs 43,282美元)、死亡率更高(5.0% vs 0.9%),机械通气、透析及经皮肾造瘘引流使用均显著增加(P<0.001)。

要点

  • 肾及肾周脓肿患者AKI发生率为32.1%,且从2016年29.9%升至2022年34.8%。
  • 与AKI相关的因素包括年龄≥45岁、男性、黑人种族、AIDS、凝血障碍、水电解质紊乱、肥胖、慢性肾病(排除终末期肾病)。
  • AKI相关并发症包括高钾血症、急性呼吸衰竭、心律失常、消化道出血、肺炎、输血、尿路感染。
  • AKI患者死亡率5.0% vs 0.9%,机械通气3.4% vs 0.9%,透析4.8% vs 0.8%,经皮肾造瘘引流32.4% vs 25.6%(均P<0.001)。
  • AKI患者中位住院时间9天 vs 5天,中位费用82,741美元 vs 43,282美元。

适用人群与场景

  • 因肾及肾周脓肿住院的患者,数据来自2016-2022年美国全国住院患者样本数据库。
  • 原文未明确列出排除标准。

诊断标准与关键阈值

  • AKI诊断依据全国住院患者样本数据库记录,原文未提供具体诊断标准或阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • AKI患者中高钾血症、急性呼吸衰竭、心律失常、消化道出血、肺炎、输血、尿路感染等并发症与AKI相关,需警惕。
  • AKI患者死亡率、机械通气、透析及经皮肾造瘘引流使用率均显著高于无AKI患者。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用全国住院患者样本数据库(2016-2022年),共纳入肾及肾周脓肿患者,其中4,896例(32.1%)发生AKI。
  • 主要终点:AKI发生;多因素logistic回归识别相关因素包括年龄≥45岁、男性、黑人种族、AIDS、凝血障碍、水电解质紊乱、肥胖、慢性肾病(排除终末期肾病)及并发症(高钾血症、急性呼吸衰竭、心律失常、消化道出血、肺炎、输血、尿路感染)。
  • 关键次要终点:AKI患者中位住院9天 vs 5天,中位费用82,741美元 vs 43,282美元,死亡率5.0% vs 0.9%,机械通气3.4% vs 0.9%,透析4.8% vs 0.8%,经皮肾造瘘引流32.4% vs 25.6%(P<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(基于全国住院患者样本数据库)。

对床旁实践的改变

  • 对肾及肾周脓肿患者应早期评估AKI风险,尤其具备年龄≥45岁、男性、黑人种族、AIDS、凝血障碍、水电解质紊乱、肥胖、慢性肾病(排除终末期肾病)等特征者。
  • AKI发生与不良结局显著相关,提示需及时干预,但原文未提供具体干预措施。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Patients diagnosed with renal and perinephric abscesses (RPA) frequently experience acute kidney injury (AKI), which is associated with poor clinical outcomes. However, large-scale, nationwide studies examining factors associated with AKI in this patient population are lacking.

OBJECTIVES: The current research aimed to identify factors associated with AKI in patients with RPA.

METHODS: A retrospective cohort study was conducted using data obtained from the National Inpatient Sample database spanning January 1, 2016, through December 31, 2022. The primary outcome assessed was the development of AKI. To identify factors associated with AKI, we performed multivariable logistic regression analysis.

RESULTS: In total, 4,896 patients (32.1%) developed AKI during hospitalization, with the occurrence rising from 29.9% in 2016 to 34.8% by 2022. Multivariable logistic regression revealed several factors associated with AKI, such as age ≥45 years, male sex, Black race, comorbidities (acquired immune deficiency syndrome, coagulopathy, fluid and electrolyte disorders, obesity and chronic kidney disease excluding end-stage renal disease), and complications (hyperkalemia, acute respiratory failure, arrhythmia, gastrointestinal hemorrhage, pneumonia, blood transfusion, urinary tract infection). Patients with AKI were associated with longer median hospital stays (9 vs. 5 days), higher median costs ($82,741 vs. $43,282), increased mortality (5.0% vs. 0.9%), and greater use of mechanical ventilation (3.4% vs. 0.9%), dialysis (4.8% vs. 0.8%), and percutaneous nephrostomy drainage (32.4% vs. 25.6%) (P < 0.001).

CONCLUSIONS: AKI commonly occurs among patients with RPA and is significantly associated with worse outcomes, highlighting the critical need for early risk assessment and prompt interventions.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wu X, Wang Y, Cheng J, et al. Factors Associated with Acute Kidney Injury and Clinical Outcomes in Patients with Renal and Perinephric Abscess: A National Inpatient Sample Analysis (2016-2022). Shock. 2025. PMID: 42584979. doi:10.1097/SHK.0000000000002753

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。